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Background:  As  part of  a series  of  feasibility  studies  following  the development  of  Canadian  vaccine
barcode  standards,  we  compared  barcode  scanning  with  manual  methods  for  entering  vaccine  data  into
electronic  client  immunization  records  in public  health  settings.
Methods: Two  software  vendors  incorporated  barcode  scanning  functionality  into  their  systems  so  that
Algoma  Public  Health  (APH)  in Ontario  and four  First  Nations  (FN)  communities  in  Alberta  could  partic-
ipate  in  our  study.  We  compared  the recording  of  client  immunization  data  (vaccine  name,  lot  number,
expiry  date)  using  barcode  scanning  of vaccine  vials  vs.  pre-existing  methods  of entering  vaccine  infor-
mation  into  the  systems.  We  employed  time  and  motion  methodology  to evaluate  time  required  for data
recording,  record  audits  to assess  data  quality,  and qualitative  analysis  of  immunization  staff  interviews
to  gauge  user  perceptions.
Results: We  conducted  both  studies  between  July  and  November  2012,  with  628  (282 barcoded)  vials
processed  for  the  APH  study,  and  749  (408  barcoded)  vials  for  the  study  in FN  communities.  Barcode
scanning  led  to signiﬁcantly  fewer  immunization  record  errors  than  using  drop-down  menus  (APH  study:
0%  vs. 1.7%;  p =  0.04)  or typing  in  vaccine  data  (FN study:  0%  vs.  5.6%;  p <  0.001).  There  was  no signiﬁcant
difference  in time  to  enter  vaccine  data  between  scanning  and  using  drop-down  menus  (27.6 s vs. 26.3  s;
p  =  0.39),  but  scanning  was  signiﬁcantly  faster  than  typing  data  into  the  record  (30.3  s vs. 41.3 s;  p  <  0.001).
Seventeen  immunization  nurses  were  interviewed;  all  noted  improved  record  accuracy  with  scanning,
but  the majority  felt that  a mo
the  2D  barcodes  on  some  vacc
Conclusion: Entering  vaccine  d
data  quality,  and  was  generall
particularly  for unit-dose  vials
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Table 1
Vaccines used at study sites.
Vaccine name Manufacturer Packaging
Barcoded vaccines
Adacel® Sanoﬁ Pasteur Single-dose vial
Adacel-Polio® Sanoﬁ Pasteur Single-dose vial
Pediacel® Sanoﬁ Pasteur Single-dose vial
Quadracel® Sanoﬁ Pasteur Single-dose vial
Td  Adsorbed® Sanoﬁ Pasteur Single-dose vial
Vaxigrip®* Sanoﬁ Pasteur Multi-dose vial
Non-barcoded vaccines
Boostrix ® GlaxoSmithKline Pre-ﬁlled syringe
Engerix B® GlaxoSmithKline Single-dose vial
Gardasil® Merck Single-dose vial
Havrix® GlaxoSmithKline Pre-ﬁlled syringe
Imovax Polio ® Sanoﬁ Pasteur Pre-ﬁlled syringe
Ixiaro® Novartis Pre-ﬁlled syringe
Menactra® Sanoﬁ Pasteur Single-dose vial
Pneumovax® Merck Single-dose vial
Prevnar® Pﬁzer Pre-ﬁlled syringe
Recombivax Merck Single-dose vial
Rotarix® GlaxoSmithKline Pre-ﬁlled syringe
Twinrix ® GlaxoSmithKline Pre-ﬁlled syringe
Typherix® GlaxoSmithKline Pre-ﬁlled syringe
Typhim Vi® Sanoﬁ Pasteur Pre-ﬁlled syringe
Vivaxim® Sanoﬁ Pasteur Pre-ﬁlled syringeJ.A. Pereira et al. / Vac
. Introduction
Barcode scanning technology enhances patient safety, reduces
rrors involving drug administration, and increases the timeliness
nd accuracy of medication-related documentation [1–5]. Since
0–60% of immunization records are missing important informa-
ion or contain errors [6–9], possibly due to the small print used
or lot number and expiry date on vaccine vials, the value of bar-
ode scanning may  extend to vaccines. In 1999, Canada’s National
dvisory Committee on Immunization (NACI) recommended plac-
ng barcodes on vaccine products to automate the recording of
accine-related data in electronic systems [10].
The Public Health Agency of Canada (PHAC) leads the Automated
dentiﬁcation of Vaccines Project Advisory Task Group (AIVP ATG),
hich includes representation from the vaccine industry, health-
are professional organizations, and barcode standard-setting
rganizations. With a mandate of providing leadership and sup-
ort for developing and implementing vaccine barcodes in Canada
11], AIVP ATG reached a consensus on vaccine barcode standards
n 2009. These include placing two-dimensional (2D) barcodes,
ith unique Global Trade Item Number (GTIN) and lot number,
nd optional expiry date, on primary packaging (Fig. 1) [11]. Based
n the GS1 System of Standards, the GTIN is a global standard for
roduct identiﬁcation. It is the foundation for electronic processes
uch as data synchronization and barcode scanning, with resul-
ant improvement in operational efﬁciencies, cost reduction, and
atient safety [12]. Canadian vaccine manufacturers have commit-
ed to adhering to the barcode standards by 2016 [13].
To  support barcode scanning feasibility studies, a collabora-
ive was formed among AIVP ATG, the PHAC/Canadian Institutes
f Health Research Inﬂuenza Research Network (PCIRN), PHAC,
nd Sanoﬁ Pasteur Ltd. We  previously studied barcode scanning
f inﬂuenza vaccine vials for recording inventory in mass immu-
ization clinics and found high barcode readability and favorable
ser perceptions [14]. However, we observed no improvement in
ecord accuracy, likely because most clinics used a single inﬂuenza
accine lot; the beneﬁts of barcode scanning may  be more appar-
nt in settings where multiple vaccines are being used, resulting
n a greater potential for errors. The objective of this study was
o compare barcode scanning with manual electronic approaches
or recording individual-level immunization data for a variety of
accines administered in public health settings.
. Methods
.1. Study design
We  conducted intervention-control feasibility studies in two
ublic health settings. The intervention involved scanning the fol-
owing vaccines labeled with 2D barcodes containing GTIN, lot
umber, and expiry date: Pediacel® (Diphtheria, Acellular Per-
ussis, Tetanus, Polio, Haemophilus inﬂuenzae type b), Quadracel®
Diphtheria, Tetanus, Acellular Pertussis, Polio), Adacel® (Tetanus,
iphtheria, Acellular Pertussis), Td Adsorbed (Diphtheria, Tetanus),
dacel®-Polio (Tetanus, Diphtheria, Acellular Pertussis, Polio), and
axigrip® (Inﬂuenza). All vaccines used are listed in Table 1.
We  compared the collection of vaccine data (vaccine name,
ot number, and expiry date) by: (1) barcode scanning of vaccine
ials with 2D barcodes (listed above); and (2) existing meth-
ds of entering vaccine information into the electronic systems
or non-barcoded vials. We  used post-immunization chart audits,
ime-and-motion studies, observation recording, and telephone
nterviews to compare the data collection approaches.
We  received ethics approval from the Health Sciences Research
thics Board at the University of Toronto, Canada.* Used at Study Site 2 only.
2.1.1. Study Site 1: Algoma Public Health, Ontario
The study was performed in Algoma Public Health (APH), one
of the 36 local public health units in Ontario, Canada. APH serves a
population of 115,870 (2011) [15], delivering the majority of vac-
cines in Sault Ste. Marie, Ontario and the surrounding area through
two general weekly immunization clinics (∼100 to 160 vaccines
administered per week) (personal communication, Susan Berger,
APH). Routine childhood and adult vaccines are given as well as
travel-related vaccines. We  recruited Intrahealth Canada Ltd., a
British Columbia-based electronic medical record (EMR) vendor
who added barcode scanning functionality to their Proﬁle software
system so that their client APH could participate (Proﬁle immuniza-
tion screen shown in Fig. 2) [16].
For barcoded vaccines, the immunizers scanned the vial to
populate the client’s record with the vaccine information (name,
lot number, expiry date). For non-barcoded vaccines, the immu-
nizers used Proﬁle’s conventional method of recording vaccine
information using drop-down menus that included all vaccines in
inventory.
Immunization staff were provided with scanners (DS4208-HC
Scanner, Motorola Ltd., United States, $260 CAD) with stands (Intel-
listand for DS42xx series, Motorola Ltd., United States, $39), and
each nurse was  trained on a one-on-one basis using dummy vials by
an APH staff member who  was  experienced with barcode scanning.
2.1.2. Study Site 2: First Nations communities, Alberta
Our second study site was  First Nations (FN) communities in
Alberta. Those belonging to First Nations are Aboriginal people in
Canada who are neither Inuit nor Metis (having Aboriginal and
European heritage) [17]. Research agreements were developed
with four First Nations communities to conduct full or partial data
collection: Siksika Nation (on-reserve population [2011], 2858),
Stoney First Nations (on-reserve population, 407), Kehewin First
Nation (on-reserve population, 900), and Cold Lake First Nations
(on-reserve population, 1235) [18]. OKAKI Health Intelligence is
an Alberta-based immunization data collection software vendor
that provides the Community Health and Information Program (CHIP)
software to >30 First Nations communities. They upgraded their
system in spring 2012 to include barcode scanning functionality
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Fig. 1. (a) Vial of Adacel®: Adacel® ’s packaging is a single-dose vial containing 0.5 mL  of vaccine; (b) Vial of Vaxigrip®: Vaxigrip® ’s packaging is a multi-dose vial containing
5.0 mL of vaccine; (c) Example of a GS1 DataMatrix: A two dimensional (2D) barcode (GS1 DataMatrix symbology) consists of printed squares or dots, spiraling outwards
from the center of the symbol. The above 2D barcode includes a 14-digit Global Trade Item Number, (GTIN), expiry date and lot number. Including the expiry date in the
barcode is an optional labeling requirement as it can be determined through lot number. Lot number and expiry date will continue to appear in human readable form on
vaccine  primary packaging as per Canadian labeling requirements. By embedding a GS1 GTIN into a barcode to identify a vaccine product, healthcare providers have the
ability  to electronically scan a vaccine product and automatically populate patient health records or immunization registries with up-to-date, accurate product information
pulled from the Vaccine Identiﬁcation Database System (VIDS). Manufacturers are responsible for (i) providing standardized product information for each vaccine GTIN in
ECCnet  Registry, a national product registry used by industry to provide accurate product information based on global standards; and (ii) publishing this information to data
r nsists
[
t
t
d
u
u
M
D
t
c
2
n
(ecipients such as VIDS; (d) Description of 2D barcode components: The barcode co
19]. CHIP requires staff to enter data through a combination of
yping data and drop-down menus (Fig. 3).
For barcoded vaccines, immunizers scanned the vial to populate
he client’s record with the vaccine name and lot number; expiry
ate was not recorded. For non-barcoded vaccines, immunizers
sed CHIP’s conventional methods (i.e., typing in lot number and
sing drop-down menus for vaccine name and other data).
Immunization staff were provided with scanners (DS6700,
otorola Ltd., United States, $522) and stands (Intellistand for
S67xx series, Motorola Ltd., Unites, States, $55), as well as a group
raining session by OKAKI staff to demonstrate the scanning pro-
ess.
.2. Data collection
After  obtaining informed consent from the immunization
urses, we collected the following:
(i) Immunization record quality – After the immunizer recorded
vaccine data, we audited the record, examining the complete-
ness  and accuracy of the relevant data ﬁelds (vaccine name, lot
number,  and expiry date [the latter for APH only]) compared
to  the information on the vial.
(ii)  Time – We  measured total time required to record vaccine
data into immunization records, comprising time required for
immunizers  to either scan the barcode data into immunization
records or enter it using the manual method. “Start time” of an
observation  was when the nurse accessed the immunization
data entry screen while “end time” was submission of data for
that  vial. For barcoded vials, a scan time was also recorded,
starting from the time the vial was placed under the scanner of product speciﬁc GTIN, the expiry date and lot number information.
to the time the vial was scanned successfully, indicated by the
population  of data into the client’s record. These data were cap-
tured  by an Excel macro to time the process, with a stopwatch
used  as backup.
iii) Barcode readability – For barcoded vaccines, we  recorded the
number  of vials for which the manual method of inputting vac-
cine  data was  required due to an unreadable barcode. Nurses
were  instructed that if they felt that a particular barcode could
not  be scanned, they could revert to the manual method at their
own  discretion.
(iv) User perceptions – We  conducted semi-structured telephone
interviews with immunizers following the data collection
period to understand perceptions of the software systems with
respect  to integration into staff workﬂow, ease of use, and accu-
racy.  As nurses were not assigned to a single treatment arm,
each  had experience with both methods (i.e., barcoding and
manual).  All immunizers were invited to be interviewed.
2.3. Sample size
Based  on earlier work and information from immunization man-
agers, we  assumed a 1% data entry error rate with barcode scanning
and 5% data entry error rate with the manual method. Collecting
data for 666 vaccinations per case study (333 barcoded vials and
333 non-barcoded vials) allowed us to detect this difference in data
quality with 80% power and 5% alpha-level.2.4. Statistical analysis
We  compared data quality of the immunization records using
z-tests, where the proportions of immunization records with one
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r more errors in the vaccine name, lot number, or expiry date
elds for barcoded vials and non-barcoded vials were compared.
e used the t-test to compare the average time required by immu-
ization staff to record vaccine data using barcode scanning and the
Fig. 3. This ﬁgure depicts the screen that is used by immunization staff td by immunization staff to enter vaccine data into the client’s immunization record
manual method. We  assessed readability of barcode scanning by
recording the number of barcoded vials that could not be scanned
successfully. Analyses were performed using STATA 10 (StataCorp
LP, College Station, United States).
o enter vaccine data into the client’s immunization record in CHIP.
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The interviews were imported into qualitative analysis software
N-Vivo Version 9.0, QSR International, Burlington, United States)
o facilitate data organization, review, coding, analysis, and explo-
ation of themes that emerged from the data. Two team members
JAP and SQ) read each transcript once to get an overall sense of the
ata, and then again to code. Consensus decision-making was used
o arrive at mutually agreed-upon coding.
. Results
For Study Site 1, we collected data from 282 barcoded vials and
46 non-barcoded vials over 21 immunization clinic days between
uly 23 and October 4 2012 (Table 2). For Study Site 2, full data col-
ection was completed in Siksika Nation and Stoney Nations for 408
arcoded vaccine vials and 341 non-barcoded vaccine vials over 25
linic days from October 15 to November 23 2012 (Table 2). User
erception data were also collected in Kehewin First Nation and
old Lake First Nations.
.1.  Data quality
Study  Site 1: We  observed zero errors with barcode scanning,
ompared to seven errors in six immunization records (1.7%) in the
anual arm (p = 0.04) (Table 3). The latter included one instance of
he nurse recording the wrong vaccine name, and three instances
ach of incorrectly recorded lot numbers and expiry dates.
Study  Site 2: We  observed zero errors for the barcode arm and 26
rrors in 19 immunization records (5.6%) for the non-barcode arm
p < 0.001) (Table 3). Eight errors were from choosing the wrong
accine name from the drop-down menu, and 18 were from typing
ot numbers incorrectly.
.2.  Time
Study Site 1: Mean time per vial to enter vaccine data did
ot differ between scanning and manual methods (27.6 s vs.
6.3 s; p = 0.39) (Table 4). The mean scan time was 8.8 s/vial
range = 0.1–94.5 s).
Study  Site 2: Barcode scanning was signiﬁcantly faster than
ntering data using the manual method (30.3 s vs. 41.3 s; p < 0.001)
Table 4). For scanning alone, the mean time was  4.4 s/vial
range = 0.29–58 s).
.3.  Readability
Study Site 1: Immunizers reverted to the manual method for
ata entry for 15 vials (5.3%). The mean scanning time before the
urse switched to manual entry was 32.9 s (range = 1.6–87.2 s).
Study Site 2: Immunizers switched to the manual method for
our (0.98%) barcoded vials. The mean scanning time before switch-
ng to manual entry was 5.1 s/vial (range = 1.2–15.3 s).
.4.  User perceptions
Study  Site 1: We  conducted interviews with eight immunization
urses (the remaining two were trainees who only administered
on-barcoded vaccines during the study). All reported that the
raining was adequate and appreciated the opportunity to prac-
ice with dummy  vials. They also noted that the designated resident
barcode scanning expert” (nurse who learned the process early on)
as valuable in supporting the adoption of the technology, helping
o resolve issues that arose. All noted the beneﬁts of scanning for
ecording accurate and complete information.
Nearly all interviewees mentioned early difﬁculties with scan-
ing, leading to the discovery that the pattern on the countertop
urface was creating interference. A blank white sheet placed under2 (2014) 2748–2755
the  scanner improved the scanning success rate. Many nurses felt
that the barcode readability was not consistent; using a particular
technique to scan one vial successfully did not always translate into
success with subsequent vials, and multiple attempts were often
needed.
“I  would like it [barcode scanner] to be more sensitive because
[.  . .]  our site was doing it yesterday and there were some [scan-
ners]  that you have to, turn and turn and up and down, and it
takes.  . . I  could’ve typed it in ten times by the time it actually
scanned it.”
-  Immunization Nurse #2
Four participants expressed a strong willingness to continue
with scanning as is, and were happy with the scanner and technique
they used during this study.
“Although there were some times with certain vaccines it [scan-
ner]  doesn’t scan as well, that can become frustrating but overall
I  liked it [scanning]. I thought, you know, we thought it was  more
accurate,  we were reducing human error. I thought it was great!
-  Immunization Nurse #6
The remaining four felt that a more sensitive scanner was
needed to improve acceptance. Resistance to change was acknowl-
edged as a potential barrier to adopting this technology, beyond
the logistics of the new method:
“[. . .]  it’s a matter of changing, if you’re ever in a change mode, it
takes  a while for people to adjust to something and if you don’t
come  from the same mindset as someone who has to do reports,
then  you don’t have the same appreciation. It’s one more thing
to  do, why  don’t we just stick with drop-down kind of thing.”
-  Immunization Nurse #5
Study Site 2: Of the seven immunization nurses interviewed,
all were satisﬁed with the training, and found the technique easy
and fast to learn; one mentioned that a one-on-one scanning ses-
sion would be helpful in the future. These nurses indicated that
they enjoyed the beneﬁts of barcode scanning and were willing to
continue using it for recording vaccine data.
“It’s more accurate, you don’t have to try to decipher people’s
writing  and people didn’t write all the information so there’s
all  that human error so this way  it’s all pre-programmed so it’s
[scanning’s]  a lot more efﬁcient in my  mind.”
- Immunization Nurse #13
All of the nurses commented that the barcodes could not always
be read by the scanners, either not working immediately or at all
despite the same technique being successful with previous vials.
This was a source of frustration for the majority of the nurses inter-
viewed. Three nurses mentioned scanning ease for inﬂuenza vials,
but challenges with single-dose childhood vaccines, speciﬁcally
Pediacel.
“I  can say though that because ﬂu are multi-dose vials, it’s a
lot  easier than the smaller Pediacel. It’s easier to scan the other
one  sometimes if you’re not holding it exactly right, it [scanner]
doesn’t  read it [vial]. But on ﬂu, either it’s a different kind of
barcode  or it’s just bigger, but it’s a lot easier. When you’re going
in,  once you found your spot, especially with the Pediacel, it
worked  more consistently, like right away. And then sometimes,
one  of them [vials] would be frustrating and there were a couple
that  I gave up on. I think after ﬁve times, you get frustrated.”
-  Immunization Nurse #12
Several nurses felt that the technology could be useful in
other immunization settings if the barcode readability issue was
resolved, proposing that current barcodes may  be too small or
too light in color. Another mentioned that barcode scanning may
J.A. Pereira et al. / Vaccine 32 (2014) 2748–2755 2753
Table  2
Case  study characteristics.
Characteristic Algoma Public Health First Nations communities
Number of clinic days observed 21 25
Number of immunization nurses 10 9
Mean number of vials/day/clinic (min, max) 29 (8, 51) 26 (2, 72)
Total number of barcoded vaccine vials 282 408
Total number of non-barcoded vaccine vials 346 341
Number of unique sites 1 2
Table 3
Error  rates for barcoded and non-barcoded methods, per study site.
Algoma Public Health First Nations Communities
Non-barcode errors Barcode errors Non-barcode errors Barcode errors
n % n % n % n %
Vaccine name 1 0.3 0 0 8 2.4 0 0
Lot  number 3 0.9 0 0 18 5.3 0 0
Expiry  date 3 0.9 0 0 N/A N/A N/A N/A
Total  errors by record ﬁelds 7 0.7 0 0 26 3.8 0 0
Total  errors by immunization record 6 1.7a 0 0a 19 5.6b 0 0b
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Ca Fisher’s exact test p-value = 0.035.
b Fisher’s exact test p-value < 0.001.
liminate even more errors if introduced earlier in the immuniza-
ion data recording process (i.e., prior to vaccine administration),
o that it could alert immunization staff to expired vaccines.
.  Discussion
We  demonstrated the feasibility and beneﬁts of barcode scan-
ing compared to manual electronic approaches of recording
ndividual-level immunization data for routine childhood and
nﬂuenza vaccines in public health settings. Barcode scanning was
ore accurate than drop-down menus, and is faster for recording
accine data compared to typing vaccine lot numbers. By thor-
ughly testing barcode scanning in live settings, we gained a better
nderstanding of the complexities of its integration into existing
orkﬂows.
Adopting new technologies in healthcare settings has often
ntroduced risks such as increased user workload, communication
reakdowns, and fragmentation of information [20,21]. In both case
tudies, our readability data indicate that users may  expect imme-
iate success with scanning. Some nurses switched from barcode
canning to the manual method when vial barcodes were not read
romptly (i.e., within 2 s). Therefore, more work is needed to ensure
ptimal barcode readability. It is important to choose a scanner
hat is both affordable for public health agencies and sufﬁciently
ensitive to read the small barcodes. GS1 Canada has developed
 scanning guide to aid new adopters in this decision [22]. Ade-
uate training must be provided to ensure comfort with scanning
able 4
omparison of time (s) between barcoded and non-barcoded methods, per study site.
Vaccine type n Mean 9
Algoma Public Health
Complete  immunization process (per vial)
Non-barcode 346 26.3 2
Barcode  282 27.6 2
Barcode  scanning only (per vial)
Barcode 282 8.8 
First  Nations Communities
Complete  immunization process (per vial)
Non-barcode 341 41.3 3
Barcode  408 30.3 2
Barcode  scanning only (per vial)
Barcode 408 4.4 and  the optimal technique, and users must have sufﬁcient techni-
cal support. Our interviews indicated that users were very satisﬁed
with the training sessions, and that the combination of one-on-one
instruction, practice time with dummy  vials, and an on-site bar-
code scanning expert is an ideal training model. Finally, vaccine
manufacturers must ensure that their production lines are printing
barcodes at an adequate darkness for scanning. Study participants
reported that the smaller unit dose vials were most problematic;
although the barcodes are the same size as those on multi-dose
inﬂuenza vials, the smaller size of the actual vial leads to greater
curvature of the barcode, which may  explain the scanning difﬁcul-
ties. These types of challenges have been previously identiﬁed in
studies evaluating the use of barcode scanning technology for med-
ication administration in hospitals and healthcare institutions in
North America. While scanning has been found to effectively reduce
the rate of human errors associated with dispensing, transcribing
and administering medications [1,4,5], it has also been problematic
to users for reasons including troublesome scanners, barcode not
being readable (smudged, torn, etc.), and inadequate training [21].
Our interviews with immunization staff also demonstrated that
users anticipate that this technology will improve record quality
and efﬁciency. The workﬂow used in this evaluation (scanning after
vaccine administration) was chosen because of the nursing prac-
tice of recording vaccine information into immunization records
following vaccination rather than before, in case the vaccine does
not end up being administered. However, it may  be worthwhile
to consider alternative processes that include scanning prior to
5% CI Median Minimum, Maximum
4.6–27.9 21.7 6.4, 121.6
5.5–29.7 22.9 1.3, 140.1
7.1–10.4 3.8 0.1, 94.5
8.9–43.8 37.0 10.2, 203.0
8.8–31.9 28.0 2.0, 116.0
3.8–5.0 2.0 0.3, 58.0
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accine administration so that issues such as wrong vaccine,
ecalled lot number, or expired product can be identiﬁed before
he client is immunized.
These  results can facilitate the adoption of this approach in
anada as well as elsewhere. The U.S. has recently adopted the
anadian vaccine barcode standards to promote harmonization,
nd consequently vaccine manufacturers are beginning to alter
heir U.S. product labeling to include 2D barcodes [23]. Investiga-
ors at the Centers for Disease Control and Prevention have initiated
 pilot project designed to determine best practices for labeling and
racking vaccines using 2D barcodes [24].
Our study had several limitations. First, we did not examine the
ffect of vaccine packaging type on outcomes. Packaging types can
ary, with single-dose vials, multi-dose vials, and preﬁlled syringes.
on-barcoded vaccines for both study sites were single-dose vials
r pre-ﬁlled syringes. For Study Site 1, all of the barcoded vaccines
sed were single-dose, while for Study Site 2, inﬂuenza vaccines
n multi-dose vials were used, in addition to single-dose vials and
re-ﬁlled syringes. Given that single-dose vials are smaller than
ulti-dose vials, and therefore have greater curvature, it is pos-
ible that the observed difference between the two  arms in Study
ite 2 may  have been larger than it would have been if only vaccines
ith single-dose vials were used. Second, APH had adopted Proﬁle
nly three months prior to the study, therefore the time required
o record vaccine data may  have been greater due to unfamiliar-
ty with a new system. Third, the number of vaccinations at APH
uring the pre-determined data collection period was  lower than
nticipated, and therefore we were unable to meet our sample size
equirements for barcoded vaccines. This may  have resulted in our
nability to detect a signiﬁcant difference in data quality between
arcode scanning and manual methods. Fourth, we  included nurse
rainees in our observation period at APH, and it is possible that
heir times to record vaccine data may  be higher than for nurses,
ue to their limited experience; however, given that only ﬁve of
he 346 observations for non-barcode vials were based on data
ecording by trainees, the impact on our study results was minimal.
ifth, in the FN study, one of the scanners was an older unit, which
ay have caused delays. Sixth, several nurses in the FN study did
ot respond to our interview requests. Although there were nine
urses observed in the FN study, there were additional nurses in
he two participating communities in which we conducted inter-
iews only without doing on-site observations. Therefore, there
ere several nurses that did not respond to our request for an inter-
iew. These individuals may  have different opinions than those
ho responded. Finally, the comparisons for both case studies
nvolved completely electronic methods; since many public health
ettings employ paper-based immunization data collection, com-
aring with paper methods may  have increased generalizability.
.  Conclusions
Our study has demonstrated the beneﬁts of barcode scanning
f routine vaccines in two diverse public health settings. Barcode
canning has good acceptability, and improvements in data qual-
ty are evident, particularly when compared to the combination of
yping in lot number and the use of drop-down menus for other
ata ﬁelds. However, further work is needed to understand and
mprove barcode readability. Future studies should focus on addi-
ional vaccination settings such as physician ofﬁces, schools, and
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